Loading organizations...
Princeton Integrated Research x Analytics (PIRXA) develops specialized software, data technology, and advanced analytical solutions. It offers design and build services for research commercialization and technology development. Leveraging expertise in data analysis and software engineering, PIRXA creates tools providing new insights for scientific and medical communities, fostering innovation.
Joseph Studholme, founder and CEO, established PIRXA as a Princeton-based health care data research and development firm. His founding insight addressed the critical need for sophisticated data and software to translate complex research into practical applications. Studholme’s experience guides the company’s focus, bridging scientific discovery and real-world impact through technology.
PIRXA's offerings benefit researchers and medical professionals, equipping them with tools to analyze intricate data. Its mission transforms complex information into actionable intelligence, accelerating scientific discovery and medical advancements, providing essential infrastructure and analytical capabilities for future breakthroughs.
Princeton Integrated Research x Analytics has raised $100K across 1 funding round.
Princeton Integrated Research x Analytics has raised $100K in total across 1 funding round.
Princeton Integrated Research x Analytics has raised $100K across 1 funding round. Most recently, it raised $100K Seed in August 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2015 | $100K Seed | — | Union Atlantic Ventures | Announced |
Princeton Integrated Research x Analytics has raised $100K in total across 1 funding round.
Princeton Integrated Research x Analytics's investors include Union Atlantic Ventures.
Princeton Integrated Research x Analytics (PIRXA) is a Princeton, New Jersey-based technology company specializing in health care data research and development.[2][3][7] It focuses on research commercialization, software design and build, and advanced technology development, serving the healthcare sector by advancing data-driven solutions.[2][3] As a portfolio-style company, PIRXA tackles complex challenges in healthcare analytics, leveraging expertise to bridge research and practical applications, with its founder also active in venture operations.[3][7]
PIRXA was founded by Joseph Studholme, an experienced entrepreneur with deep roots in software and Princeton University.[3][7] Studholme's career began selling the first Macintosh computers at the Princeton University Store in 1984, evolving into co-founding and serving as COO of Restricted Stock Systems (RSS), a VC-backed financial software firm that grew from a 2000 napkin sketch to New Jersey Tech Council Early Stage Company of the Year by 2007.[3] He later launched PIRXA as a health care data R&D firm and became a founding member of Union Atlantic Ventures, focusing on deal origination and management coaching; his role as an Executive in Residence at Princeton's Technology Licensing & New Ventures underscores his commitment to commercializing university innovations.[3][7]
PIRXA rides the wave of AI-driven healthcare analytics and data commercialization, where rising demand for prescriptive insights meets exploding health data volumes.[1][2][3] Timing aligns with post-2020 acceleration in health tech R&D, fueled by AI integration and needs for transparent, interpretable models amid regulatory scrutiny.[4] Market forces like personalized medicine, Edge-AI equity, and research-to-product pipelines favor PIRXA's niche, as seen in Princeton's startup ecosystem spawning AI, energy, and battery analytics ventures.[4] It influences by channeling university IP into healthcare, aiding broader shifts toward data-optimized decisions in a sector projected for sustained growth.[1][3][4]
PIRXA is poised to expand in AI-enhanced health analytics, capitalizing on trends like glass-box AI transparency and scalable data platforms amid healthcare's digital transformation.[2][3][4] Expect deeper university collaborations, potential venture scaling via Studholme's networks, and growth in Rx-focused software amid rising demand for equitable, Edge-AI solutions.[3][4][7] Its influence may evolve by powering more Princeton spinouts, solidifying its role in commercializing health tech innovations that started as research breakthroughs.
